title: Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.
abstract: The Epstein-Barr virus (EBV) transactivator protein (ZEBRA) is an immediate-early protein that plays an important role in the switch from latency to productive cycle in EBV virus. ZEBRA is an important marker of EBV reactivation. In order to diagnose EBV infection status correctly and timely, a novel immunoassay was developed based on an indirect time-resolved fluoroimmunoassay (TRFIA) for Zta IgA, which used recombinant Zta antigen as solid-phase antigen and Eu(3+)-labeled mouse antihuman IgA as corresponding probe. The precision, sensitivity, specificity test, and stability of the TRFIA kit were evaluated, and comparison with the traditional enzyme-linked immunosorbent assay (ELISA) was also investigated. The cutoff value for the TRFIA was 2.5. Intra- and interassay coefficients of variation for the TRFIA were 2.45-3.30% and 3.38-4.61% respectively. There was no cross-reactivity with the antibodies of cytomegalovirus (CMV) or herpes simplex virus (HSV) types 1 and 2, or other potential interferences. The established assay kit also behaved better in sensitivity and stability than the ELISA one. Additionally, the results in 382 serum samples using two analytical methods showed there was good agreement between the TRFIA and commercial ELISA kit. In the current study, the results demonstrated that the TRFIA that was developed for Zta IgA detection was more sensitive and reliable for the diagnosis of EBV infection and had potential value in automation and high-throughput screening.
authors: State Key Laboratory of Organ Failure Research, Institute of Antibody Engineering, School of Biotechnology, Southern Medical University , Guangzhou, People's Republic of China .
authors: Juanjuan
authors: J
authors: Chen
authors: Tiancai
authors: T
authors: Liu
authors: Zhenhua
authors: Z
authors: Chen
authors: Jingyuan
authors: J
authors: Hou
authors: Yingsong
authors: Y
authors: Wu
authors: Ming
authors: M
authors: Li
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D003955:Diagnostic Tests, Routine / Q000379:methods*; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis*; D015200:Fluoroimmunoassay / Q000379:methods; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D044967:Serum / Q000276:immunology; D015534:Trans-Activators / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; C063676:BZLF1 protein, Herpesvirus 4, Human; D007070:Immunoglobulin A; D015534:Trans-Activators
references: Int J Cancer. 2005 Mar 1;113(6):998-1001
references: 15515016
references: Intervirology. 1998;41(6):278-84
references: 10325538
references: Anal Chim Acta. 2012 Jul 13;734:93-8
references: 22704477
references: Sci Am. 1979 Jul;241(1):48-59
references: 221971
references: Comp Immunol Microbiol Infect Dis. 1979;2(2-3):213-20
references: 228895
references: Res Virol. 1996 Jan-Feb;147(1):53-66
references: 8882341
references: Proc Natl Acad Sci U S A. 1985 Jun;82(12):4085-9
references: 2987963
references: Cancer. 1994 Nov 1;74(9):2414-24
references: 7922994
references: Lancet. 1994 Feb 5;343(8893):333-5
references: 7905149
references: J Med Virol. 1999 Apr;57(4):383-9
references: 10089051
references: J Clin Microbiol. 2006 Apr;44(4):1459-67
references: 16597877
references: Clin Diagn Lab Immunol. 1996 May;3(3):363-4
references: 8705686
references: Luminescence. 2013 May-Jun;28(3):401-6
references: 22715159
references: J Virol. 1987 Dec;61(12):3672-9
references: 2824806
references: J Biomed Sci. 1996 May-Jun;3(3):159-169
references: 11725096
references: Lancet. 2006 May 6;367(9521):1521-32
references: 16679166
references: Cell. 1994 Jun 17;77(6):791-3
references: 8004668
references: Int J Cancer. 1991 Jul 9;48(5):647-9
references: 1649137
references: Tumour Biol. 2014 Jul;35(7):6879-86
references: 24737587
references: J Clin Microbiol. 2008 Apr;46(4):1374-80
references: 18256216
references: Haematologica. 2007 Feb;92(2):e24-5
references: 17405750
references: Cancer Immunol Immunother. 1994 Jan;38(1):68-70
references: 8299121
references: Pediatr Blood Cancer. 2011 Jan;56(1):154-5
references: 20842751
references: Int J Cancer. 1982 Feb 15;29(2):139-41
references: 6895884
references: J Infect Dis. 1991 Jan;163(1):53-6
references: 1845809
references: Semin Cancer Biol. 2014 Jun;26:99-115
references: 24751797
references: Cancer Lett. 2013 Aug 28;337(1):1-7
references: 23689138